We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+31.46%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$91.5M
AUM Growth
+$23.2M
(+34%)
Cap. Flow
+$1.78M
Cap. Flow
% of AUM
1.95%
Top 10 Holdings %
Top 10 Hldgs %
59.03%
Holding
57
New
10
Increased
4
Reduced
9
Closed
4
Top Buys
| 1 |
Stereotaxis
STXS
|
+$4.59M |
| 2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
+$2.74M |
| 3 |
Protalix BioTherapeutics
PLX
|
+$1.59M |
| 4 |
HSTO
Histogen Inc. Common Stock
HSTO
|
+$1.07M |
| 5 |
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
|
+$969K |
Top Sells
| 1 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$2.52M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$2.28M |
| 3 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$821K |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$734K |
| 5 |
InfuSystem Holdings
INFU
|
+$707K |
Sector Composition
| 1 | Healthcare | 60.11% |
| 2 | Financials | 1.25% |
| 3 | Communication Services | 0.38% |
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML